LONDON, March 30 (Reuters) - Britain could approve Novavax's
COVID-19 vaccine next month, the chief investigator for
the shot's trial told the Evening Standard newspaper.
“The regulator will do a very detailed and thorough review
and will decide in good time,” said Professor Paul Heath, chief
investigator for the Novavax jab trial in the UK.
“I would hope it would be in the spring, possibly end of
April.”
(Reporting by Guy Faulconbridge; Editing by Kate Holton)